Search research articles
Contact Us
Filters
Showing results (21-30 of 33) with videos related to
Page
of 4
Sort By:
JACC. Cardiovascular Imaging
|
January 14, 2012
Correlation between arterial FDG uptake and biomarkers in peripheral artery disease
Kelly S Myers, James H F Rudd, Eric P Hailman, et al.
Health Policy (Amsterdam, Netherlands)
|
August 26, 2020
An overview of critical decision-points in the medical product lifecycle: Where to include patient preference information in the decision-making process?
Chiara Whichello, Karin Schölin Bywall, Jonathan Mauer, et al.
Bioinformation
|
July 26, 2012
FunSys: Software for functional analysis of prokaryotic transcriptome and proteome
Pablo de Sá, Anne Pinto, Rommel Thiago Jucá Ramos, et al.
Journal of Lipid Research
|
December 20, 2011
Changes in lipoprotein subfraction concentration and composition in healthy individuals treated with the CETP inhibitor anacetrapib
Ronald M Krauss, Kathleen Wojnooski, Joseph Orr, et al.
JIMD Reports
|
June 8, 2026
Patient Preferences in Neuromuscular Diseases: Insights for Future Drug Development
Aura Cecilia Jimenez-Moreno, Alasdair Blain, Cathy Anne Pinto, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
April 13, 2019
Understanding Patients' Preferences: A Systematic Review of Psychological Instruments Used in Patients' Preference and Decision Studies
Selena Russo, Chiara Jongerius, Flavia Faccio, et al.
The Patient
|
March 4, 2021
Patient Preferences in Rare Diseases: A Qualitative Study in Neuromuscular Disorders to Inform a Quantitative Preference Study
A Cecilia Jimenez-Moreno, Eline van Overbeeke, Cathy Anne Pinto, et al.
Frontiers in Pharmacology
|
September 4, 2023
How can patient preferences be used and communicated in the regulatory evaluation of medicinal products? Findings and recommendations from IMI PREFER and call to action
Rosanne Janssens, Liese Barbier, Mireille Muller, et al.
Frontiers in Microbiology
|
February 15, 2021
Genomic Characterization of Multidrug-Resistant <i>Escherichia coli</i> BH100 Sub-strains
Rodrigo Carvalho, Flavia Aburjaile, Marcus Canario, et al.
Wellcome Open Research
|
August 16, 2021
A study protocol for quantifying patient preferences in neuromuscular disorders: a case study of the IMI PREFER Project
Aura Cecilia Jimenez-Moreno, Cathy Anne Pinto, Bennett Levitan, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 33) with videos related to
Sort By:
Page
of 4
JACC. Cardiovascular Imaging
|
January 14, 2012
Correlation between arterial FDG uptake and biomarkers in peripheral artery disease
Kelly S Myers, James H F Rudd, Eric P Hailman, et al.
Health Policy (Amsterdam, Netherlands)
|
August 26, 2020
An overview of critical decision-points in the medical product lifecycle: Where to include patient preference information in the decision-making process?
Chiara Whichello, Karin Schölin Bywall, Jonathan Mauer, et al.
Bioinformation
|
July 26, 2012
FunSys: Software for functional analysis of prokaryotic transcriptome and proteome
Pablo de Sá, Anne Pinto, Rommel Thiago Jucá Ramos, et al.
Journal of Lipid Research
|
December 20, 2011
Changes in lipoprotein subfraction concentration and composition in healthy individuals treated with the CETP inhibitor anacetrapib
Ronald M Krauss, Kathleen Wojnooski, Joseph Orr, et al.
JIMD Reports
|
June 8, 2026
Patient Preferences in Neuromuscular Diseases: Insights for Future Drug Development
Aura Cecilia Jimenez-Moreno, Alasdair Blain, Cathy Anne Pinto, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
April 13, 2019
Understanding Patients' Preferences: A Systematic Review of Psychological Instruments Used in Patients' Preference and Decision Studies
Selena Russo, Chiara Jongerius, Flavia Faccio, et al.
The Patient
|
March 4, 2021
Patient Preferences in Rare Diseases: A Qualitative Study in Neuromuscular Disorders to Inform a Quantitative Preference Study
A Cecilia Jimenez-Moreno, Eline van Overbeeke, Cathy Anne Pinto, et al.
Frontiers in Pharmacology
|
September 4, 2023
How can patient preferences be used and communicated in the regulatory evaluation of medicinal products? Findings and recommendations from IMI PREFER and call to action
Rosanne Janssens, Liese Barbier, Mireille Muller, et al.
Frontiers in Microbiology
|
February 15, 2021
Genomic Characterization of Multidrug-Resistant <i>Escherichia coli</i> BH100 Sub-strains
Rodrigo Carvalho, Flavia Aburjaile, Marcus Canario, et al.
Wellcome Open Research
|
August 16, 2021
A study protocol for quantifying patient preferences in neuromuscular disorders: a case study of the IMI PREFER Project
Aura Cecilia Jimenez-Moreno, Cathy Anne Pinto, Bennett Levitan, et al.
Page
of 4